CNBC
Search documents
SoftBank shares plunge as much as 10% after selling Nvidia stake
CNBC· 2025-11-12 00:58
Group 1 - SoftBank Group sold its entire stake in Nvidia for $5.83 billion to fund a $22.5 billion investment in OpenAI [1][2] - The sale of 32.1 million Nvidia shares occurred in October, alongside a reduction in SoftBank's T-Mobile position, raising an additional $9.17 billion [2] - SoftBank's CFO emphasized the importance of providing investment opportunities while maintaining financial strength [2] Group 2 - SoftBank's Vision Fund was an early investor in Nvidia, building a $4 billion stake in 2017 before fully divesting in January 2019 [3] - Despite the sale, SoftBank remains connected to Nvidia through broader business interests [3] - Analysts view SoftBank's actions as a bullish signal for its investment strategy rather than a bearish one [3] Group 3 - OpenAI is a central focus of SoftBank's GenAI portfolio, while hardware investments continue through its stake in Arm Holdings [4] - SoftBank has a controlling stake in Arm, which designs chips for mobile and AI processors [4] Group 4 - Other tech stocks in the region, including Advantest and Tokyo Electron, experienced declines following SoftBank's announcement [5] - TSMC, the largest contract chipmaker, and SK Hynix also saw minor decreases in their stock prices [5]
There could be a buying opportunity in consumer packaged goods stocks, Jim Cramer says
CNBC· 2025-11-12 00:00
Group 1: Investment Opportunities in Packaged Goods - Investment in packaged goods stocks, such as Procter & Gamble and Kimberly-Clark, is suggested as they are seen as undervalued winners in the sector [1][2] - The packaged goods sector has faced challenges due to high inflation and low growth, but inflation may be nearing its peak, potentially reducing costs for consumer giants [2] - Kimberly-Clark's acquisition of Kenvue is noted, along with praise for its brands, while Procter & Gamble is recognized for its innovation and scale to lower product costs [3] Group 2: Broader Market Insights - Clorox is highlighted as a poor performer in the S&P 500, but its products, including Burt's Bees and Hidden Valley, are still favored [3] - General Mills is mentioned as a risky investment, particularly if there is speculation about a takeover, due to the impact of weight loss drugs on food stocks [3] - Beyond traditional packaged goods, opportunities in pharmaceuticals are emphasized, with Johnson & Johnson and Amgen identified as solid picks amid expected industry mergers [4]
Cramer's Lighting Round: 'You want to stay in' Amphenol
CNBC· 2025-11-11 23:59
Amphenol: "It's just such a great stock...You want to stay in that cable play."Stock Chart IconStock chart iconAquestive Therapeutics' year-to-date stock performance.Aquestive Therapeutics: "I think it's a very interesting spec."Joby Aviation: "They're losing too much money."watch nowJim Cramer's Guide to InvestingClick here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter. ...
As OpenAI spends billions, Jim Cramer says the number of winning AI stocks could narrow
CNBC· 2025-11-11 23:30
Core Viewpoint - Concerns are raised about the potential underperformance of artificial intelligence companies, particularly OpenAI, due to its significant financial commitments and reliance on debt financing [1][2][3] Group 1: OpenAI's Financial Commitments - OpenAI has made deals with various tech companies worth hundreds of billions, raising concerns about its ability to meet these obligations without borrowing money [2] - Recent comments from OpenAI's CFO suggested the possibility of seeking government support, which unsettled investors despite later clarifications that government funding is not currently being pursued [2][3] Group 2: Industry Implications - The reliance on debt financing in the AI sector is viewed as riskier, potentially making companies more vulnerable to financial distress [3] - The situation with OpenAI could have broader implications for the industry, similar to historical precedents in the railroad sector where heavy borrowing led to bankruptcies [3] Group 3: Market Outlook - The current investment environment is shifting towards a focus on profitability rather than speculative gains, indicating a potential increase in market volatility with fewer winners and more losers [4] - There is a call for OpenAI to consider entering the IPO market to raise capital and clarify its financial position [3]
Goldman nabs its largest-ever fee on M&A deal — plus, another good sign for Dover
CNBC· 2025-11-11 20:04
Market Overview - The stock market was mixed, with the Nasdaq under pressure due to weakness in megacap tech stocks following CoreWeave's disappointing quarterly earnings report, leading to a decline of over 15% in its stock [1] - The S&P 500 and Dow advanced as investors rotated out of tech and into sectors like health care, energy, and consumer staples [1] Company Updates Boeing - Boeing delivered 53 jets in October, bringing its total for 2025 to 493, with 39 deliveries being 737 MAX jets [1] - The FAA approved Boeing to increase 737 production to 42 jets per month from 38, indicating a gradual increase in deliveries [1] - Boeing recorded a non-cash charge of $4.9 billion in Q3 due to delays in the certification process for its 777-9 program, pushing the first delivery to 2027 [1] Goldman Sachs - Goldman Sachs is set to earn its largest fee ever for a mergers and acquisitions deal, amounting to $110 million for advising on the $55 billion take-private transaction of Electronic Arts [1] - This fee is significant for Goldman's investment banking division, which has seen a rebound in M&A activity and IPOs after years of dormancy [1] Dover - Dover's shares rose 2.5% after announcing a $500 million accelerated share repurchase (ASR) program, expected to complete by November 12 [1] - The ASR follows a better-than-expected Q3 earnings report and positive outlook for next year, with CEO Richard Tobin indicating no revenue declines forecasted for the portfolio [1] DuPont - DuPont announced a $500 million ASR as part of a $2 billion share repurchase program, with shares hitting a new high and rallying nearly 20% since splitting from Qnity Electronics [1]
The shutdown put jobs and inflation data on hold. Here's when it could be back — and what it might say
CNBC· 2025-11-11 20:03
Core Insights - The U.S. federal government shutdown has delayed nearly all federal economic data releases for September and October, but it appears to be nearing an end, which will allow for the resumption of data collection and reporting [2][3] - The Bureau of Labor Statistics (BLS) is responsible for key reports such as nonfarm payrolls and the Consumer Price Index (CPI), which are expected to be released soon after the government reopens [4] - Economic indicators suggest a slowing labor market and inflation remaining above the Federal Reserve's comfort level, with expectations of gradual deceleration through 2026 [6][8] Economic Data Delays - The shutdown has caused significant delays in the release of important economic reports, including nonfarm payrolls, CPI, retail sales, and personal spending and income [2][5] - Goldman Sachs anticipates that the October jobs report will be released shortly after the reopening, potentially by next Tuesday or Wednesday, but other major data releases may be delayed by at least a week [4][5] Federal Reserve Insights - Federal Reserve Chair Jerome Powell indicated that despite the data freeze, alternative data sources suggest that the macroeconomic picture has not changed significantly [6][7] - Powell noted that the labor market is gradually cooling, and inflation remains elevated, with the key inflation rate estimated at 2.8% for September, above the Fed's 2% target [7][8] Economic Growth Projections - The Atlanta Fed's GDPNow tracker estimates third-quarter growth at a 4% rate, while Goldman Sachs projects fourth-quarter growth at 1.3%, an upward revision from previous forecasts, indicating a full-year growth pace of 2% [9]
AMD's Lisa Su sees 35% annual sales growth driven by 'insatiable' AI demand
CNBC· 2025-11-11 19:21
Core Insights - AMD's overall revenue growth is projected to expand to approximately 35% per year over the next three to five years, driven by high demand for AI chips [1][2] - The AI data center business is expected to grow at about 80% per year, potentially reaching tens of billions in sales by 2027 [2] - AMD aims to capture a "double-digit" market share in the data center AI chip market within the next three to five years, currently dominated by Nvidia [3] Company Developments - AMD is experiencing a surge in data center spending for AI, with companies investing hundreds of billions in GPU chips for AI applications [4] - A partnership with OpenAI was announced, involving the sale of billions of dollars in Instinct AI chips, starting with enough chips in 2026 to utilize 1 gigawatt of power [5] - Long-term deals with Oracle and Meta were also highlighted, indicating strong customer traction [5] Market Context - The AI chip market is currently led by Nvidia, which holds over 90% market share and has a market cap exceeding $4.6 trillion, compared to AMD's valuation of approximately $387 billion [3] - AMD is positioned as the only other major GPU developer aside from Nvidia, providing an alternative for companies seeking to increase capacity and control costs [4]
CoreWeave CEO responds to data center delays as stock plunges. Core Scientific shares fall
CNBC· 2025-11-11 17:03
Core View - CoreWeave shares fell 13% following CEO Mike Intrator's comments on delays at a third-party data center that impacted full-year guidance in the latest earnings report [1] Group 1: Company Performance - CEO Mike Intrator stated that all aspects of the quarter went as planned except for delays at a singular data center [1] - Intrator emphasized that the issue was related to one data center provider, although he did not confirm the identity of the provider [3][4] - CoreWeave's quarterly earnings call revealed that there are 41 data centers in their portfolio, indicating that the impact is limited to one site [4] Group 2: Market Reactions - Following the announcement, Core Scientific shares dropped 7%, reflecting investor concerns about the delays [3] - CNBC's Jim Cramer highlighted that the delays are occurring at multiple locations connected to Core Scientific, which CoreWeave attempted to acquire for $9 billion earlier this year [2][3]
Analysts call this lagging portfolio stock a buy — plus, what's behind Nvidia's decline
CNBC· 2025-11-11 16:27
Market Overview - The S&P 500 and Nasdaq experienced declines due to pressure on Big Tech following CoreWeave's disappointing quarterly results, which included a lowered revenue outlook, leading to a 14% drop in CoreWeave's shares [1] - Wall Street is also reacting to soft labor market data, with ADP's payroll tracker indicating an average decline of 11,250 jobs over the four weeks ending October 25 [1] Company-Specific Updates - Linde's shares rose over 1% after UBS upgraded the company from a hold-equivalent rating to a buy, despite a price target reduction from $507 to $500, citing expected earnings-per-share growth in 2026 as a positive catalyst [1] - Nvidia's stock fell approximately 3% after SoftBank announced the sale of its entire stake in the company, which is part of a strategy to fund a $22.5 billion investment in OpenAI; this development does not raise concerns for Nvidia, maintaining the "own, don't trade" thesis [1] Additional Insights - The rapid-fire segment at the end of the video covered stocks including CoreWeave, Paramount Skydance, Amgen, Dutch Bros, and Coterra Energy [1] - Jim Cramer will be signing copies of his new book on market strategies, indicating ongoing engagement with investors [1]
Rocket Lab rises 5% on record third-quarter revenue, launch backlog
CNBC· 2025-11-11 16:25
Core Insights - Rocket Lab's stock increased by up to 5% following the announcement of record revenues in Q3, driven by an increase in launch deals and a growing backlog [1] Financial Performance - The company reported Q3 revenue of $155 million, exceeding the analyst forecast of $152 million and representing a 48% increase from approximately $105 million a year ago [2] - Rocket Lab posted a smaller-than-expected loss of 3 cents per share, compared to the anticipated loss of 10 cents per share [2] - The company reported an adjusted EBITDA loss of $26.3 million, which was higher than the previously forecasted loss range of $21 million to $23 million and above the analyst expectation of $22.2 million [7] Future Guidance - Rocket Lab provided strong guidance for the current quarter, expecting revenues between $170 million and $180 million, slightly above the analyst forecast of $172 million [3] - The company anticipates adjusted EBITDA losses in Q4 to range between $23 million and $29 million, exceeding the $13 million loss forecast by analysts [7] Operational Highlights - Rocket Lab has a record backlog with 49 rocket launches on contract, having signed 17 new deals in Q3 and plans to complete over 20 launches by year-end [3] - The company is on track to achieve a new annual launch record, as stated by CEO Peter Beck [4] Market Context - Competition in the space technology sector is intensifying, with increased reliance on independent contractors by the U.S. government and NASA, including competitors like SpaceX [5] - Rocket Lab's stock has more than doubled this year and surged nearly 270% over the last twelve months, despite a 13% pullback in November amid broader market conditions [6]